These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 18945403
1. Mathematical models of cervical cancer prevention in Latin America and the Caribbean. Goldie SJ, Diaz M, Constenla D, Alvis N, Andrus JK, Kim SY. Vaccine; 2008 Aug 19; 26 Suppl 11():L59-72. PubMed ID: 18945403 [Abstract] [Full Text] [Related]
5. Model-based impact and cost-effectiveness of cervical cancer prevention in the Extended Middle East and North Africa (EMENA). Kim JJ, Sharma M, O'Shea M, Sweet S, Diaz M, Sancho-Garnier H, Seoud M. Vaccine; 2013 Dec 30; 31 Suppl 6():G65-77. PubMed ID: 24331822 [Abstract] [Full Text] [Related]
8. Cost-effectiveness analysis of a quadrivalent human papilloma virus vaccine in Mexico. Reynales-Shigematsu LM, Rodrigues ER, Lazcano-Ponce E. Arch Med Res; 2009 Aug 30; 40(6):503-13. PubMed ID: 19853192 [Abstract] [Full Text] [Related]
9. Exploring the cost-effectiveness of HPV vaccination in Vietnam: insights for evidence-based cervical cancer prevention policy. Kim JJ, Kobus KE, Diaz M, O'Shea M, Van Minh H, Goldie SJ. Vaccine; 2008 Jul 29; 26(32):4015-24. PubMed ID: 18602731 [Abstract] [Full Text] [Related]
10. Cost-effectiveness analysis of the introduction of the human papillomavirus vaccine in Honduras. Aguilar IB, Mendoza LO, García O, Díaz I, Figueroa J, Duarte RM, Perdomo G, Garcia AG, Janusz CB. Vaccine; 2015 May 07; 33 Suppl 1():A167-73. PubMed ID: 25919157 [Abstract] [Full Text] [Related]
14. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Muñoz N, Franco EL, Herrero R, Andrus JK, de Quadros C, Goldie SJ, Bosch FX. Vaccine; 2008 Aug 19; 26 Suppl 11():L96-L107. PubMed ID: 18945407 [Abstract] [Full Text] [Related]
15. Prevention of cervical cancer in rural China: evaluation of HPV vaccination and primary HPV screening strategies. Canfell K, Shi JF, Lew JB, Walker R, Zhao FH, Simonella L, Chen JF, Legood R, Smith MA, Nickson C, Qiao YL. Vaccine; 2011 Mar 16; 29(13):2487-94. PubMed ID: 21211586 [Abstract] [Full Text] [Related]
16. Cost-effectiveness of HPV 16, 18 vaccination in Brazil. Goldie SJ, Kim JJ, Kobus K, Goldhaber-Fiebert JD, Salomon J, O'shea MK, Xavier Bosch F, de Sanjosé S, Franco EL. Vaccine; 2007 Aug 14; 25(33):6257-70. PubMed ID: 17606315 [Abstract] [Full Text] [Related]
18. Screening, prevention and treatment of cervical cancer -- a global and regional generalized cost-effectiveness analysis. Ginsberg GM, Edejer TT, Lauer JA, Sepulveda C. Vaccine; 2009 Oct 09; 27(43):6060-79. PubMed ID: 19647813 [Abstract] [Full Text] [Related]
19. Cost-effectiveness analysis of a cervical cancer vaccine in five Latin American countries. Colantonio L, Gómez JA, Demarteau N, Standaert B, Pichón-Rivière A, Augustovski F. Vaccine; 2009 Sep 04; 27(40):5519-29. PubMed ID: 19616499 [Abstract] [Full Text] [Related]
20. Cost-effectiveness of cervical cancer prevention in Central and Eastern Europe and Central Asia. Berkhof J, Bogaards JA, Demirel E, Diaz M, Sharma M, Kim JJ. Vaccine; 2013 Dec 31; 31 Suppl 7():H71-9. PubMed ID: 24332299 [Abstract] [Full Text] [Related] Page: [Next] [New Search]